ARCHIVES

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

This article is from The Cancer Letter archive.

Vol. 09 No. 05 | February 4, 1983

Download PDF Visit The Full Archive

Related Articles

New Treatment Approach To Treating Brain Tumor

April 26, 2002

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

Funding opportunities listed.

January 16, 2004

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

1.7% Cut Expected in NCI Budget Under Deficit Agreement

November 24, 1989

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994